COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

Detalles Bibliográficos
Autores principales: Kaminski, Hannah, Gigan, Mickael, Vermorel, Agathe, Charrier, Manon, Guirle, Laura, Jambon, Frederic, Lacapère, Arthur, Ménard, Coline, Moreau, Karine, Neau-Cransac, Martine, Novion, Marine, Pribat, Frederique, Taton, Benjamin, Borde, Sébastien, Burguet, Laure, Martinez, Charlie, Jasiek, Magali, D’Halluin, Pauline, Lafon, Marie-Edith, Merville, Pierre, Couzi, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297679/
https://www.ncbi.nlm.nih.gov/pubmed/35870641
http://dx.doi.org/10.1016/j.kint.2022.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297679/
https://www.ncbi.nlm.nih.gov/pubmed/35870641
http://dx.doi.org/10.1016/j.kint.2022.07.008

Ejemplares similares